Rubicon Research Limited
Rubicon Research Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: RUBICON and BSE: 544578 (ISIN INE506V01022).
It has a market capitalisation of ₹24,544 crore, a last close of ₹1,487 on 2026-10-19, a one-year return of 140.3%.
Valuation: a price-to-earnings ratio of 85.16x, a price-to-book ratio of 19.04x, a dividend yield of 0.1%.
Profitability: return on equity of 27.0%, return on capital employed of 24.3%, an operating margin of 23.3%.
Balance sheet and ownership: debt-to-equity of 0.20x, promoter holding of 51.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 24,544 |
| Last close | ₹1,487 |
| P/E (TTM) | 85.16x |
| P/B | 19.04x |
| Dividend yield | 0.1% |
| ROE (FY) | 27.0% |
| ROCE (FY) | 24.3% |
| Operating margin (TTM) | 23.3% |
| Debt / equity | 0.20x |
| Promoter holding | 51.3% |
| 1-year return | 140.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means